Even as the Trump administration takes significant steps to reshape federal cannabis policy, the Pentagon has issued a clear directive: marijuana remains strictly forbidden for all military service members and civilian employees of the Department of War (DOW).
In a new one-page memo dated July 9, 2026, the DOW emphasized its commitment to maintaining a “drug-free workplace to protect national security, public safety, and operational readiness.”
This internal warning comes on the heels of an April order by U.S. Acting Attorney General Todd Blanche, which immediately transitioned marijuana products regulated by a state medical cannabis license—along with any FDA-approved marijuana products—from Schedule I to Schedule III of the Controlled Substances Act (CSA). Meanwhile, an ongoing administrative hearing is deliberating even broader marijuana rescheduling.
Interestingly, the Pentagon’s memo appears to overlook the fact that this specific medical rescheduling has already taken place. The document notes that “if implemented,” the reform “would not decriminalize marijuana under Federal law.”
Anthony J. Tata, the Under Secretary of War for Personnel and Readiness, authored the memo, reminding personnel that the Uniform Code of Military Justice (UCMJ) still strictly prohibits “the wrongful use, possession, manufacture, or distribution of marijuana, and attempts to commit such acts.” Tata made it clear that these offenses remain punishable under military law, regardless of whether a state or local jurisdiction has legalized recreational use or authorized the sale of medical marijuana at state dispensaries.
“Service members who violate the UCMJ may be held appropriately accountable, including through judicial, nonjudicial, or administrative action,” Tata wrote, adding that the department’s civilian employees are equally bound by the Drug-Free Workplace Program. He did note one exception, stating that the prohibitions “do not apply to formulations approved as drugs by the FDA with a valid prescription for a legitimate medical purpose.”
However, the military’s strict interpretation may clash with recent analyses from the Congressional Research Service (CRS). The CRS published a report explaining that certified patients possessing medical marijuana from state-licensed dispensaries now enjoy certain protections under the new Schedule III classification. According to the CRS, the April order “appears to authorize end users to possess marijuana for medical use without a CSA-compliant prescription.”
Despite the shifting legal landscape and the CRS’s findings, the military has consistently maintained a hardline approach to cannabis and its derivatives. Earlier this year, the Army reminded soldiers of its strict “zero-tolerance” policy, which extends to all forms of cannabis, including hemp-derived products like lotions and hair care items. Similarly, previous memos from the Air Force, Navy, and Coast Guard have repeatedly warned personnel against using hemp-derived cannabinoids such as CBD and delta-8 THC, emphasizing that even products like CBD-infused hand sanitizer or hemp granola could compromise military readiness.
In a slight pivot toward leniency regarding past use, the Army did enact a new policy in April 2026. Recruits no longer need to obtain a waiver to enlist if they have a single prior conviction for possessing marijuana or drug paraphernalia. But once in uniform, the Pentagon’s message is unmistakable: cannabis, in any form, remains off the table.
Dabbin-Dad Newsroom
